While ACE is the major kinin-destroying peptidase in the extracellular fluid (19, 20), ACE inhibitor-induced angioedema is reportedly resistant to the plasma kallikrein inhibitor ecallantide and to the B2R antagonist icatibant (21, 22). The gene discussed is ACE; the disease is angioedema.